Arnold, M., Abnet, C. C. & Neale, R. E. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 159, 335–349 (2020).

Article  PubMed  Google Scholar 

Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263 (2024).

Article  PubMed  Google Scholar 

Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 68, 2179 LP–2172185 (2019).

Article  Google Scholar 

Howren, A. et al. Trends in the incidence of young-onset colorectal cancer with a focus on years approaching screening age: a population-based longitudinal study. J. Natl Cancer Inst. 113, 863–868 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Matsuda, T. & Saika, K. Cancer burden in Japan based on the latest cancer statistics: need for evidence-based cancer control programs. Ann. Cancer Epidemiol. 2, 2–2 (2018).

Article  Google Scholar 

Jung, K. W., Won, Y. J., Kong, H. J. & Lee, E. S. Cancer Statistics in Korea: incidence, mortality, survival and prevalence in 2016. Cancer Res. Treat. 51, 417–430 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Ford, A. C., Forman, D., Hunt, R. H., Yuan, Y. & Moayyedi, P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 348, g3174 (2014).

Article  PubMed  PubMed Central  Google Scholar 

The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 4, 934–947 (2019).

Li, G. Z., Doherty, G. M. & Wang, J. Surgical management of gastric cancer: a review. JAMA Surg. 157, 446–454 (2022).

Article  PubMed  Google Scholar 

Matsuda, T. et al. Recent updates in the surgical treatment of colorectal cancer. Ann. Gastroenterol. Surg. 2, 129–136 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Bien, J. & Lin, A. A review of the diagnosis and treatment of metastatic colorectal cancer. JAMA 325, 2404–2405 (2021).

Article  PubMed  Google Scholar 

Chan, D. L. H., Segelov, E. & Wong, R. S. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer. Cochrane Database Syst. Rev. 6, CD007047 (2017).

Bang, Y.-J. et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376, 687–697 (2010).

Article  CAS  PubMed  Google Scholar 

Javle, M., Borad, M. J. & Azad, N. S. Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study. Lancet Oncol. 22, 1290–1300 (2021).

Article  CAS  PubMed  Google Scholar 

Finn, R. S., Qin, S. & Ikeda, M. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N. Engl. J. Med. 382, 1894–1905 (2020).

Article  CAS  PubMed  Google Scholar 

Rindi, G. & Wiedenmann, B. Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine. Nat. Rev. Endocrinol. 16, 590–607 (2020).

Article  PubMed  Google Scholar 

Kelly, C. M., Gutierrez Sainz, L. & Chi, P. The management of metastatic GIST: current standard and investigational therapeutics. J. Hematol. Oncol. 14, 2 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borad, M. J. et al. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. PLoS Genet. 10, e1004135 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Lee, C. H., Wu, D. C. & Lee, J. M. Anatomical subsite discrepancy in relation to the impact of the consumption of alcohol, tobacco and betel quid on esophageal cancer. Int. J. Cancer 120, 1755–1762 (2007).

Article  CAS  PubMed  Google Scholar 

Obermannová, R., Alsina, M. & Cervantes, A. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33, 992–1004 (2022).

Article  PubMed  Google Scholar 

Wang, G. Q., Abnet, C. C. & Shen, Q. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 54, 187–192 (2005).

Article  PubMed  PubMed Central  Google Scholar 

M, P., MI, C. & RC, F. Endoscopic management of early adenocarcinoma and squamous cell carcinoma of the esophagus: screening, diagnosis, and therapy. Gastroenterology 154, 421–436 (2018).

Article  Google Scholar 

Lagergren, J., Smyth, E., Cunningham, D. & Lagergren, P. Oesophageal cancer. Lancet 390, 2383–2396 (2017).

Article  PubMed  Google Scholar 

Chen, J., Kwong, D. L. & Cao, T. Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics. Dis. Esophagus 28, 84–89 (2015).

Article  CAS  PubMed  Google Scholar 

Wu, C., Wang, Z. & Song, X. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat. Genet. 46, 1001–1006 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Probst, A., Aust, D., Märkl, B., Anthuber, M. & Messmann, H. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. Endoscopy 47, 113–121 (2015).

PubMed  Google Scholar 

Cho, J. W., Choi, S. C. & Jang, J. Y. Lymph node metastases in esophageal carcinoma: an endoscopist’s view. Clin. Endosc. 47, 523–529 (2014).

Article  PubMed  PubMed Central  Google Scholar 

van Hagen, P. et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N. Engl. J. Med. 366, 2074–2084 (2012).

Article  PubMed  Google Scholar 

Bedenne, L. et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J. Clin. Oncol. 25, 1160–1168 (2007).

Article  CAS  PubMed  Google Scholar 

Stahl, M. et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J. Clin. Oncol. 23, 2310–2317 (2005).

Article  PubMed  Google Scholar 

Vincent, J., Mariette, C. & Pezet, D. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. Eur. J. Cancer 51, 1683–1693 (2015).

Article  PubMed  Google Scholar 

Markar, S., Gronnier, C. & Duhamel, A. Salvage surgery after chemoradiotherapy in the management of esophageal cancer: is it a viable therapeutic option? J. Clin. Oncol. 33, 3866–3873 (2015).

Article  CAS  PubMed  Google Scholar 

Herskovic, A. et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N. Engl. J. Med. 326, 1593–1598 (1992).

Article  CAS  PubMed  Google Scholar 

Wong, R. & Malthaner, R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst. Rev. 2010, CD002092 (2001).

Google Scholar 

Crosby, T., Hurt, C. N. & Falk, S. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer. Br. J. Cancer 116, 709–716 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moehler, M. et al. Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial. Ann. Oncol. 31,